The Effect of Mask Design on Ventilation Parameters in COPD and OHS Patients on Long-term Home Non-invasive Ventilation. An Experimental Study.
NCT ID: NCT06972589
Last Updated: 2025-05-15
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
NA
20 participants
INTERVENTIONAL
2025-05-31
2026-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Assessment of Breathing Pattern During NIV
NCT06682286
Efficacy of NIV Masks in COPD
NCT04947852
A Novel Unidirectional Face Mask During NPPV in COPD Patients
NCT00972868
Effect of Face Masks on Pulmonary Function in Patients With COPD
NCT05742880
Health Outcomes With CPAP or NIV in Patients With COPD and a Sleep Related Breathing Disorder
NCT05623709
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
* The participants are put on their prescribed airway pressure support with the first randomized mask.
* After at least 60 minutes of recording, participants are awakened to switch back to the second mask. They are then allowed to sleep uninterrupted for the rest of the night.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Noninvasive ventilation (CPAP or bilevel) with the investigational mask
Investigational Mask
Wear mask to enable the delivery of noninvasive ventilation (CPAP or bilevel) therapy during sleep.
Noninvasive ventilation (CPAP or bilevel) with the conventional mask
Conventional mask
Wear mask to enable the delivery of noninvasive ventilation (CPAP or bilevel) therapy during sleep.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Investigational Mask
Wear mask to enable the delivery of noninvasive ventilation (CPAP or bilevel) therapy during sleep.
Conventional mask
Wear mask to enable the delivery of noninvasive ventilation (CPAP or bilevel) therapy during sleep.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Prescribed nocturnal NIV for COPD or OHS
* Able to complete an overnight sleep study
* Comfortable to sleep on a standard double bed
* Capacity to complete informed consent
Exclusion Criteria
* Prescribed IPAP above 25 cmH2O
* Allergic to adhesive of the sensors
* Self-reported cold/flu symptoms
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Fisher and Paykel Healthcare
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
William Good, Medical degree
Role: PRINCIPAL_INVESTIGATOR
Middlemore Hospital, New Zealand
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Fisher and Paykel Healthcare Sleep Laboratory
Auckland, , New Zealand
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Role: backup
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CIA-356
Identifier Type: OTHER
Identifier Source: secondary_id
U1111-1322-0270
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.